Literature DB >> 22159232

What are the differences in outcomes between right-sided active infective endocarditis with and without left-sided infection?

Abderahman Kamaledeen1, Christopher Young, Rizwan Q Attia.   

Abstract

A best evidence topic in cardiac surgery was written according to a structured protocol. The question addressed was: in patients with isolated right-sided infective endocarditis (RSE) is the outcome of surgical management the same as in patients with or without left-sided involvement? Altogether, 419 papers were found using the reported search, six of which represented the best evidence to answer the clinical question. Two studies point towards better outcomes with isolated RSE. In one paper, mortality was significantly lower in isolated RSE patients (P = 0.0093) for the duration of the follow-up time (median 488 patient-years). Two studies reported early mortality (<30 days) for RSE patients at 3.6 and 3.8%, respectively. Combined right- and left-sided endocarditis (RLSE) patients were found to have a poorer pre-operative clinical presentation than isolated RSE patients with a greater requirement for inotropic support (P < 0.006) and the likelihood of an emergency operation (P < 0.001). They had a poorer intra-operative course with a higher incidence of cardiac abscess formation (P < 0.001). One study suggested that there is no significant difference in in-hospital and long-term mortality between intravenous drug abuse (IVDA) patients and non-IVDA patients. Left-heart involvement in the IVDA group was 61.5%. This was in-line with the published literature, demonstrating a rise in RLSE in IVDA compared with non-IVDA patients. Three articles looking at isolated left-sided endocarditis (LSE) gave mortality rates in the surgical group to be 27.1, 27.8 and 38%, respectively. In one study, the LSE mortality was not different for native vs. prosthetic valve infection (OR 0.65, 95% CI 0.23-1.87). After propensity matching and adjusting for hazards, the complication rate in the LSE group was higher and this translated to a higher mortality rate. We conclude from the literature that outcomes are more favourable with lower early and late mortality for isolated RSE patients over pure LSE or combined RLSE.

Entities:  

Mesh:

Year:  2011        PMID: 22159232      PMCID: PMC3279982          DOI: 10.1093/icvts/ivr012

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  7 in total

1.  [Surgical treatment of isolated right-sided infective endocarditis].

Authors:  Lin Zhang; Chang-qing Gao; Sheng-li Jiang; Chong-lei Ren
Journal:  Zhonghua Wai Ke Za Zhi       Date:  2010-03-01

2.  Towards evidence-based medicine in cardiothoracic surgery: best BETS.

Authors:  Joel Dunning; Brian Prendergast; Kevin Mackway-Jones
Journal:  Interact Cardiovasc Thorac Surg       Date:  2003-12

3.  Survivor treatment selection bias and outcomes research: a case study of surgery in infective endocarditis.

Authors:  Raymond W Sy; Paul G Bannon; Matthew S Bayfield; Chris Brown; Leonard Kritharides
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-08-04

4.  The impact of valve surgery on 6-month mortality in left-sided infective endocarditis.

Authors:  Imad M Tleyjeh; Hassan M K Ghomrawi; James M Steckelberg; Tanya L Hoskin; Zaur Mirzoyev; Nandan S Anavekar; Felicity Enders; Sherif Moustafa; Farouk Mookadam; W Charles Huskins; Walter R Wilson; Larry M Baddour
Journal:  Circulation       Date:  2007-03-19       Impact factor: 29.690

5.  Endocarditis caused by Staphylococcus aureus: A reappraisal of the epidemiologic, clinical, and pathologic manifestations with analysis of factors determining outcome.

Authors:  Manuel L Fernández Guerrero; Julio J González López; Ana Goyenechea; Julián Fraile; Miguel de Górgolas
Journal:  Medicine (Baltimore)       Date:  2009-01       Impact factor: 1.889

6.  Infective endocarditis in intravenous drug abusers: patterns of presentation and long-term outcomes of surgical treatment.

Authors:  Antonio Carozza; Luca Salvatore De Santo; Gianpaolo Romano; Alessandro Della Corte; Fabio Ursomando; Michelangelo Scardone; Giuseppe Caianiello; Maurizio Cotrufo
Journal:  J Heart Valve Dis       Date:  2006-01

7.  Surgical treatment of right-sided active infective endocarditis with or without involvement of the left heart: 20-year single center experience.

Authors:  Michele Musci; Henryk Siniawski; Miralem Pasic; Onnen Grauhan; Yuguo Weng; Rudolf Meyer; Charles A Yankah; Roland Hetzer
Journal:  Eur J Cardiothorac Surg       Date:  2007-04-06       Impact factor: 4.191

  7 in total
  4 in total

1.  Tricuspid valve endocarditis.

Authors:  Syed T Hussain; James Witten; Nabin K Shrestha; Eugene H Blackstone; Gösta B Pettersson
Journal:  Ann Cardiothorac Surg       Date:  2017-05

2.  Intravenous drug abuse and tricuspid valve endocarditis: Growing trends in the Middle East Gulf region.

Authors:  Prashanth Panduranga; Seif Al-Abri; Jawad Al-Lawati
Journal:  World J Cardiol       Date:  2013-11-26

3.  A Rare Presentation of Infective Endocarditis Due to Serratia marcescens.

Authors:  Kajol Shah; Sarthak Patel; Sana Rashid; Meghana Subramanian; Victor Cueto
Journal:  Cureus       Date:  2022-03-07

4.  Candida Infective Endocarditis: A Retrospective Study of Patient Characteristics and Risk Factors for Death in 703 United States Cases, 2015-2019.

Authors:  Jonathan P Huggins; Samuel Hohmann; Michael Z David
Journal:  Open Forum Infect Dis       Date:  2020-12-18       Impact factor: 3.835

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.